Nicola Pozzi (@LabPozzi) header
Nicola Pozzi (@LabPozzi) profile picture

Associate Professor St. Louis University School of Medicine researching #antiphospholipid Syndrome, mechanisms of blood clotting, next-gen #antithrombotics

St Louis, MO
Joined August 2018
Photo by Nicola Pozzi (@LabPozzi)Photo by Nicola Pozzi (@LabPozzi)Photo by Nicola Pozzi (@LabPozzi)Photo by Nicola Pozzi (@LabPozzi)Photo by Nicola Pozzi (@LabPozzi)Photo by Nicola Pozzi (@LabPozzi)Photo by Nicola Pozzi (@LabPozzi)
Novel insights into #APS extend beyond #Thrombosis to NETosis, #ComplementActivation and #MicrobiomeDysbiosis. The 2023 ACR/EULAR criteria refine diagnosis. Adjunctive therapies such as HCQ, rituximab and eculizumab show therapeutic potential: pmc.ncbi.nlm.nih.gov/article… #MedTwitter
1
10
1
17
1,148
🏅Celebrating 50 Years of Service: Honoring Dr. Terry Moore’s Legacy in #Rheumatology | @SSMHealthSTL #InternalMedicine 🩺🏥 🫶🏼The IM Department is privileged to celebrate Dr. Moore’s remarkable 50 years of dedication and leadership in building the legacy of our Rheumatology division. Over the past five decades, Dr. Moore has: 🔹 Pioneered approaches that have shaped how #autoimmune diseases are diagnosed and managed. 🔹 Mentored countless trainees, faculty, and colleagues who continue to carry his impact forward. 🔹 Contributed groundbreaking insights into the role of laboratory studies + the art of clinical diagnosis in guiding patient care. Beyond his scientific and clinical achievements, Dr. Moore’s commitment to #mentorship, #collaboration, & #innovation has left a lasting mark on our institution and the broader medical community. 🌟 🙏🏽 @RaviNayakMD➕Sally Day➕others for organizing a special event including Dr. Moore's #GrandRounds lecture on ‘Autoimmunity and Laboratory Studies in Connective Tissue Disease’, tributes & networking 🤝🏽 August 22, 2025 🫶🏼 Dr. Raymond Slavin for heartfelt tribute to Dr. Moore 🎤 Please join us in celebrating Dr. Moore's extraordinary career & enduring contributions to research, education, and patient care. 👏🏽 #SLUProud #SLUResearch #Rheumatology #ConnectiveTissueDisease #MedicalEducation #Mentorship #CelebratingExcellence | @SLU_Official | @slusom | @SSMHealth | @nephrom | @renginels | @Barisafsar75 | @GkamelMD | @sagun_goyal | @linamariat50445 🩺🏥
1
3
19
750
GRASP: a model for protein complex structure prediction that integrates data from crosslinking, covalent labeling, chemical shift perturbation, and deep mutational scanning experiments. @PKU_CCME @Turnstiles14 nature.com/articles/s41592-0…
23
4
107
10,639
Nicola Pozzi retweeted
Congratulations to 2025 APSACTION Silvia Pierangeli Young Scholar Award (in collaboration with APS Foundation of America) Recipients: Alice Barinotti, Zeynep Erton, Alex Luta, Liala Moschetti, Andrew Song. During #ICAPA25, Alice and Zeynep received their certificates in person.
2
4
256
Nicola Pozzi retweeted
Is someone you love at risk for an aortic aneurysm? This Aortic Disease Awareness Month, take a moment to learn the risk factors, understand who should be screened, and find out how testing can help save lives: bidmc.org/aorticscreening
1
1
1
539
Nicola Pozzi retweeted
Latest publication in @jlipidres “The Risk of Going Outside: Amino Phospholipids in Rheumatoid Arthritis” by @LabPozzi et al. jlr.org/article/S0022-2275(2… @ASBMB
1
2
73
🧬 New in @RPTHjournal. Led by @ShreyaAgarwalMD 
We share a case series of #TMA pts with Plasminogen mutations ✅Variable response to complement blockade ✅Structural mapping by @LabPozzi provides insights into potential mechanisms!! rpthjournal.org/article/S247…
2
4
14
1,056
The 3-decade-old competition that enabled the emergence and evaluate of AlphaFold has run out of NIH funding. The program will be terminated in weeks. This is terminating success. science.org/content/article/…
13
113
14
372
30,946
Nicola Pozzi retweeted
ASH is proud to recognize 11 hematologists whose groundbreaking research and leadership have transformed the understanding and care of blood disorders. Congratulations to all! 👏 🔗 ow.ly/EsgX50WbEwx #Hematology #ASHAwards
5
12
13
74
32,052
Patients with cancer are at high risk of clinically relevant bleeding, regardless of anticoagulation use. ow.ly/upqz50UgFrV #thrombosisandhemostasis #clinicaltrialsandobservations
2
18
33
4,289
I have had the honor of serving on the @HTRStoday 2025 Scientific Symposium planning committee over the last year. There is going to be a great program. We have a record number of abstracts submitted. Make plans now to attend in March 2025!!
1
2
10
521
Nicola Pozzi retweeted
Protein Disulfide Isomerase (PDI) is an exciting new target for the treatment of thrombosis. This study uncovers the mechanistic basis by which two promising compounds, quercetin-3-O-rutinoside and bepristat-2a, regulate PDI. An important step toward the development of PDI-targeting drug. ✍️@LabPozzi jthjournal.org/article/S1538…
5
1
15
2,361
Nicola Pozzi retweeted
Free scientific illustrations for biologists! 😍 @NIH has released a library of 500+ free scientific illustrations to create figures, presentations, and illustrations! all freely available in the public domain. Retweet and spread the message! bioart.niaid.nih.gov/
45
2,338
94
5,513
583,591
Nicola Pozzi retweeted
T-48 hrs until the start of our 3rd Annual @WashUHeme Retreat! Excited to hear about the latest research from our trainees & faculty, and especially thrilled to welcome @aswolberg for the Evan Sadler Special Lectureship! #hematology @WashUDeptMed
1
3
1
27
1,717
Nicola Pozzi retweeted
Does inflammation interfere with lupus anticoagulant testing in the Russel Vioer venom assay? 🐍 Read this article from Michael Hardy and team to find out : rpthjournal.org/article/S247…
5
7
965
Nicola Pozzi retweeted
On cover #August Dilemmas in the diagnosis and management of antiphospholipid syndrome #JTHiC @connors_md jthjournal.org/article/S1538…
1
10
18
1,953
Interesting 🤓D-dimer for patients on VKA vs DOAC: impact on the validity of D-dimer to make decision for extended anticoagulation 📊 @BloodAdvances Congrats @flora_peyvandi ashpublications.org/bloodadv…
15
37
1,955